Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

France set to become even tougher for medtech as elections loom: the details

This article was originally published in Clinica

Executive Summary

2012 is set to be a year full of important decisions impacting the French landscape, brought on by the climate of uncertainty resulting from recent healthcare product scandals. Alexandre Regniault, partner at the Paris office of law firm Simmons & Simmons, reflects on the current climate and the impact of the latest French regulatory measures

You may also be interested in...



No easy choice: managing infectious waste from self-treating patients in France

What are the rules in France regarding infectious medical waste that is generated by self-treating patients? Alexandre Regniault, partner at the Paris office of law firm Simmons & Simmons, explains the pros and cons of the two options open to medical device companies

The revision of the EU medical device directives and variations in national laws

How successful have the EU member states been in implementing the revision of the medical device directives into national law? And has this been done in a harmonised way? Alexandre Regniault and colleagues report on variations that have resulted from deviations from the original directives and their impact.

The revision of the EU medical device directives and variations in national laws

How successful have the EU member states been in implementing the revision of the medical device directives into national law? And has this been done in a harmonised way? Alexandre Regniault and colleagues report on variations that have resulted from deviations from the original directives and their impact.

Topics

UsernamePublicRestriction

Register

LL1121650

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel